A preliminary study on SLAMF6 expression in patients with severe aplastic anemia.
10.3760/cma.j.issn.0253-2727.2018.11.011
- Author:
Li Jie ZENG
1
;
Chun Yan LIU
;
Shao Xue DING
;
Tian ZHANG
;
Zong Hong SHAO
;
Rong FU
Author Information
1. Department of Hematology, General Hospital, Tianjin Medical University, Tianjin 300052, China.
- Publication Type:Journal Article
- Keywords:
Aplastic anemia;
SLAMF6;
T lymphocyte subsets
- MeSH:
Anemia, Aplastic;
Bone Marrow;
CD8-Positive T-Lymphocytes;
Flow Cytometry;
Humans;
Perforin;
Signaling Lymphocytic Activation Molecule Family
- From:
Chinese Journal of Hematology
2018;39(11):927-931
- CountryChina
- Language:Chinese
-
Abstract:
Objective: To explore the expression of SLAMF6 on CD8(+) T cells in patients with severe aplastic anemia (SAA) and its correlation with disease immune status. Methods: By flow cytometry (FCM), SLAMF6 expression level in peripheral blood CD8(+) T cells was detected in 21 patients with SAA and 15 normal controls respectively from February 2017 to April 2018. The correlation between SLAMF6 expression level and hematopoietic functions, including HGB, PLT, the neutrophil granulocyte and reticulocyte absolute value in peripheral blood, hyperplasia degree (percentage of granulocytes, erythrocytes, lymphocytes and megakaryocytes in bone marrow) and perforin, granzyme B, IFN-γ expression level in CD8(+) T cells were evaluated. To further confirm the effect of SLAMF6 on CD8(+) T cells, anti-SLAMF6 Ab was used to block SLAMF6 pathway (IgG as control), and FCM was used to detect the perforin, granzyme B, and IFN-γ production of CD8(+) T cells. Results: The expression of SLAMF6 on CD8(+) T cells in untreated SAA patients[(56.29±12.97)%]was significantly lower than that of normal controls[(80.96±7.36)%](t=-7.672, P<0.001). The expression of SLAMF6 on CD8(+) T cells in SAA patients were positively correlated with the HGB, PLT, the neutrophil granulocyte and reticulocyte absolute value in peripheral blood, percentage of granulocytes, erythrocytes in bone marrow (all P<0.05), but they were negatively correlated with the percentage of lymphocytes in bone marrow, and the expression of perforin, granzyme B, and IFN-γ of CD8(+) T cells (all P<0.05). After blocking SLAMF6 pathway by anti-SLAMF6 Ab, the expression levels of perforin, granzyme B and IFN-γ in SAA patients were significantly higher than those in the untreated group, and the differences were statistically significant (all P<0.05). Conclusions: SLAMF6 is significantly down-regulated on CD8(+) T cells in SAA patients, which may act as a negative immunoregulatory molecule participating in the mechanism of SAA by affecting the functional molecules secretion on CD8(+) T cells.
